• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用能谱 X 射线分析法对双膦酸盐相关性颌骨骨坏死患者病损颌骨中阿仑膦酸钠的定量分析。

Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.

机构信息

Robert Koch Institute, Centre for Biological Security, Berlin, Germany, European Union.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Oct;114(4):480-6. doi: 10.1016/j.oooo.2012.06.006.

DOI:10.1016/j.oooo.2012.06.006
PMID:22986243
Abstract

OBJECTIVE

Recently, specific in vitro bisphosphonate concentrations have been established for reaching a toxic threshold that could result in the induction of bisphosphonate-related osteonecrosis of the jaw (BRONJ), but these data have not been validated in vivo. The purpose of this study was to quantify the concentration of bisphosphonates (BPs) in the diseased jaw bone of patients experiencing BRONJ.

STUDY DESIGN

We hypothesized that if the average natural nitrogen content of mammalian bone is known, the excess of nitrogen in the jaw bone of BRONJ patients is likely to reflect the concentration of amino-BP. To test our hypothesis, jaw bone specimens from patients with BRONJ were acquired after sequestrectomy and analyzed by energy-dispersive X-ray spectroscopy (EDS).

RESULTS

The EDS analysis of the bone demonstrated a highly linear correlation between increasing concentrations of BP and the increasing percentage of nitrogen measured at the bone surfaces (R(2) = .9851, P = .0149).

CONCLUSIONS

SEM/EDS can be a valuable tool for assessing BP concentration in jaw bone and provides important insight into BP pharmacokinetics and BRONJ.

摘要

目的

最近,已经确定了特定的体外双膦酸盐浓度,以达到可能导致双膦酸盐相关性下颌骨坏死(BRONJ)的毒性阈值,但这些数据尚未在体内得到验证。本研究的目的是定量测定发生 BRONJ 的患者病颌骨中的双膦酸盐(BPs)浓度。

研究设计

我们假设,如果已知哺乳动物骨骼的平均天然氮含量,BRONJ 患者颌骨中的过量氮很可能反映了氨基-BP 的浓度。为了验证我们的假设,在施行清创术后从 BRONJ 患者中获得颌骨标本,并通过能谱 X 射线光谱仪(EDS)进行分析。

结果

对骨骼的 EDS 分析表明,BP 浓度的增加与在骨表面测量的氮百分比的增加之间呈高度线性相关(R(2) =.9851,P =.0149)。

结论

SEM/EDS 可以成为评估颌骨中 BP 浓度的有价值工具,并为 BP 药代动力学和 BRONJ 提供重要的见解。

相似文献

1
Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.采用能谱 X 射线分析法对双膦酸盐相关性颌骨骨坏死患者病损颌骨中阿仑膦酸钠的定量分析。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Oct;114(4):480-6. doi: 10.1016/j.oooo.2012.06.006.
2
Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.用于预测接受双膦酸盐治疗患者颌骨坏死发生情况的血清学骨标志物。
J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.
3
[Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].[维生素D与双膦酸盐相关颌骨坏死(BRONJ)]
Clin Calcium. 2012 Jan;22(1):83-90.
4
Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.瑞典颌骨坏死与口服双膦酸盐有关。
J Oral Maxillofac Surg. 2014 Jan;72(1):76-82. doi: 10.1016/j.joms.2013.06.221. Epub 2013 Aug 29.
5
Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.口服双膦酸盐治疗骨质疏松症导致的颌骨骨坏死:87 例意大利多医院回顾性研究。
Eur J Intern Med. 2013 Dec;24(8):784-90. doi: 10.1016/j.ejim.2013.05.011. Epub 2013 Jun 12.
6
Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.口服与静脉注射双膦酸盐所致双膦酸盐相关颌骨坏死的预后比较。
Int J Oral Maxillofac Surg. 2015 Jul;44(7):840-4. doi: 10.1016/j.ijom.2015.03.013. Epub 2015 Apr 8.
7
A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.一种针对含氮双膦酸盐(N-BPs)相关颌骨坏死的策略:尝试用非N-BP依替膦酸替代N-BPs。
Biol Pharm Bull. 2016;39(9):1549-54. doi: 10.1248/bpb.b16-00041.
8
Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.口服双膦酸盐和类固醇相关颌骨骨坏死的消退——系列病例分析
J Oral Maxillofac Surg. 2010 May;68(5):1055-63. doi: 10.1016/j.joms.2009.12.030.
9
Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.双膦酸盐相关颌骨骨坏死的外科治疗结果:33例手术病例回顾
J Oral Maxillofac Surg. 2009 May;67(5):943-50. doi: 10.1016/j.joms.2008.12.057.
10
Molecular interaction between bisphosphonates and human bone: a preliminary study on osteonecrosis sequesters of the jaw.双膦酸盐与人骨之间的分子相互作用:关于颌骨骨坏死死骨片的初步研究
Bull Group Int Rech Sci Stomatol Odontol. 2011 Sep 23;50(1):52-3.

引用本文的文献

1
Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.牙科中的双膦酸盐:历史观点、不良反应和新应用。
Bone. 2021 Jun;147:115933. doi: 10.1016/j.bone.2021.115933. Epub 2021 Mar 20.
2
Copper accumulation in the sequestrum of medication-related osteonecrosis of the jaw.铜在药物相关性颌骨坏死死骨中的蓄积。
Bone Rep. 2015 Aug 10;3:40-47. doi: 10.1016/j.bonr.2015.08.001. eCollection 2015 Dec.
3
Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review.
按机制对股骨头坏死的各种治疗方法综述
Exp Ther Med. 2014 Sep;8(3):700-706. doi: 10.3892/etm.2014.1811. Epub 2014 Jun 26.
4
Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.乳腺癌患者的双膦酸盐相关颌骨坏死
Eur J Orthop Surg Traumatol. 2015 Jan;25(1):29-37. doi: 10.1007/s00590-013-1293-z. Epub 2013 Sep 14.
5
Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw.用于评估双膦酸盐相关性颌骨骨坏死风险的群体药代动力学和药效学建模。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Feb;115(2):224-32. doi: 10.1016/j.oooo.2012.08.455. Epub 2012 Dec 12.